Zipped folder with data spreadsheets for <i>Leishmania</i> inhibitory concentrations (leishmania_ic50) and nectar and pollen flavonoid concentrations (nectar.pollen.flavonoids).
Intracellular amastigote drug susceptibility against miltefosine (MIL), paromomycin (PMM), pentavalent antimonials (SbV), trivalent antimonials (SbIII) and amphotericin B (AmB). The presented IC50-val
In silico prediction of antileishmanial activity using quantitative structure–activity relationship (QSAR) models has been developed on limited and small datasets. Nowadays, the availability of large
In the present study a series of 34 synthetic ligustrazine-containing α, β-Unsaturated carbonyl-based compounds and oximes, recognized as anticancer compounds were assessed against protozoa of the Try
Background/ObjectivesHuman leishmaniases are parasitic diseases causing severe morbidity and mortality. No vaccine is available and numerous factors limit the use of current therapies. There is thus a
6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazole derivatives were initially studied for tuberculosis within a backup program for the clinical trial agent pretomanid (PA-824). Phenotypic screening of r
